nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—SLC22A2—Progesterone—uterine cancer	0.246	0.437	CbGbCtD
Memantine—CYP2A6—Progesterone—uterine cancer	0.196	0.349	CbGbCtD
Memantine—CYP2C19—Progesterone—uterine cancer	0.0812	0.144	CbGbCtD
Memantine—CYP2B6—Doxorubicin—uterine cancer	0.039	0.0693	CbGbCtD
Memantine—Pancytopenia—Epirubicin—uterine cancer	0.000168	0.000399	CcSEcCtD
Memantine—Hypotension—Etoposide—uterine cancer	0.000168	0.000398	CcSEcCtD
Memantine—Gastritis—Doxorubicin—uterine cancer	0.000168	0.000398	CcSEcCtD
Memantine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000167	0.000397	CcSEcCtD
Memantine—Muscular weakness—Doxorubicin—uterine cancer	0.000167	0.000397	CcSEcCtD
Memantine—Dysuria—Epirubicin—uterine cancer	0.000166	0.000393	CcSEcCtD
Memantine—Neutropenia—Epirubicin—uterine cancer	0.000166	0.000393	CcSEcCtD
Memantine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000165	0.00039	CcSEcCtD
Memantine—Asthma—Doxorubicin—uterine cancer	0.000164	0.000389	CcSEcCtD
Memantine—Influenza—Doxorubicin—uterine cancer	0.000164	0.000389	CcSEcCtD
Memantine—Dysphagia—Doxorubicin—uterine cancer	0.000164	0.000389	CcSEcCtD
Memantine—Pollakiuria—Epirubicin—uterine cancer	0.000164	0.000388	CcSEcCtD
Memantine—Paraesthesia—Etoposide—uterine cancer	0.000161	0.000383	CcSEcCtD
Memantine—Weight increased—Epirubicin—uterine cancer	0.000161	0.000382	CcSEcCtD
Memantine—Pancreatitis—Doxorubicin—uterine cancer	0.000161	0.000381	CcSEcCtD
Memantine—Weight decreased—Epirubicin—uterine cancer	0.00016	0.00038	CcSEcCtD
Memantine—Dyspnoea—Etoposide—uterine cancer	0.00016	0.00038	CcSEcCtD
Memantine—Hyperglycaemia—Epirubicin—uterine cancer	0.00016	0.000379	CcSEcCtD
Memantine—Somnolence—Etoposide—uterine cancer	0.00016	0.000379	CcSEcCtD
Memantine—Angina pectoris—Doxorubicin—uterine cancer	0.00016	0.000379	CcSEcCtD
Memantine—Pneumonia—Epirubicin—uterine cancer	0.000159	0.000377	CcSEcCtD
Memantine—Infestation NOS—Epirubicin—uterine cancer	0.000158	0.000374	CcSEcCtD
Memantine—Infestation—Epirubicin—uterine cancer	0.000158	0.000374	CcSEcCtD
Memantine—Vomiting—Dactinomycin—uterine cancer	0.000158	0.000374	CcSEcCtD
Memantine—Bronchitis—Doxorubicin—uterine cancer	0.000158	0.000374	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000157	0.000371	CcSEcCtD
Memantine—Rash—Dactinomycin—uterine cancer	0.000157	0.000371	CcSEcCtD
Memantine—Decreased appetite—Etoposide—uterine cancer	0.000156	0.00037	CcSEcCtD
Memantine—Pancytopenia—Doxorubicin—uterine cancer	0.000156	0.000369	CcSEcCtD
Memantine—Renal failure—Epirubicin—uterine cancer	0.000155	0.000368	CcSEcCtD
Memantine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000155	0.000368	CcSEcCtD
Memantine—Fatigue—Etoposide—uterine cancer	0.000155	0.000367	CcSEcCtD
Memantine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000155	0.000367	CcSEcCtD
Memantine—Constipation—Etoposide—uterine cancer	0.000154	0.000364	CcSEcCtD
Memantine—Pain—Etoposide—uterine cancer	0.000154	0.000364	CcSEcCtD
Memantine—Urinary tract infection—Epirubicin—uterine cancer	0.000154	0.000364	CcSEcCtD
Memantine—Conjunctivitis—Epirubicin—uterine cancer	0.000154	0.000364	CcSEcCtD
Memantine—Neutropenia—Doxorubicin—uterine cancer	0.000153	0.000363	CcSEcCtD
Memantine—Dysuria—Doxorubicin—uterine cancer	0.000153	0.000363	CcSEcCtD
Memantine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000152	0.000361	CcSEcCtD
Memantine—Pollakiuria—Doxorubicin—uterine cancer	0.000151	0.000359	CcSEcCtD
Memantine—Haematuria—Epirubicin—uterine cancer	0.000151	0.000357	CcSEcCtD
Memantine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000149	0.000354	CcSEcCtD
Memantine—Weight increased—Doxorubicin—uterine cancer	0.000149	0.000354	CcSEcCtD
Memantine—Epistaxis—Epirubicin—uterine cancer	0.000149	0.000353	CcSEcCtD
Memantine—Weight decreased—Doxorubicin—uterine cancer	0.000148	0.000352	CcSEcCtD
Memantine—Sinusitis—Epirubicin—uterine cancer	0.000148	0.000351	CcSEcCtD
Memantine—Feeling abnormal—Etoposide—uterine cancer	0.000148	0.000351	CcSEcCtD
Memantine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000148	0.000351	CcSEcCtD
Memantine—Nausea—Dactinomycin—uterine cancer	0.000147	0.00035	CcSEcCtD
Memantine—Agranulocytosis—Epirubicin—uterine cancer	0.000147	0.000349	CcSEcCtD
Memantine—Pneumonia—Doxorubicin—uterine cancer	0.000147	0.000349	CcSEcCtD
Memantine—Gastrointestinal pain—Etoposide—uterine cancer	0.000147	0.000348	CcSEcCtD
Memantine—Infestation NOS—Doxorubicin—uterine cancer	0.000146	0.000347	CcSEcCtD
Memantine—Infestation—Doxorubicin—uterine cancer	0.000146	0.000347	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000145	0.000344	CcSEcCtD
Memantine—Bradycardia—Epirubicin—uterine cancer	0.000144	0.000342	CcSEcCtD
Memantine—Renal failure—Doxorubicin—uterine cancer	0.000144	0.000341	CcSEcCtD
Memantine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000143	0.00034	CcSEcCtD
Memantine—Urticaria—Etoposide—uterine cancer	0.000143	0.000338	CcSEcCtD
Memantine—Haemoglobin—Epirubicin—uterine cancer	0.000142	0.000338	CcSEcCtD
Memantine—Rhinitis—Epirubicin—uterine cancer	0.000142	0.000337	CcSEcCtD
Memantine—Abdominal pain—Etoposide—uterine cancer	0.000142	0.000337	CcSEcCtD
Memantine—Body temperature increased—Etoposide—uterine cancer	0.000142	0.000337	CcSEcCtD
Memantine—Conjunctivitis—Doxorubicin—uterine cancer	0.000142	0.000337	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—uterine cancer	0.000142	0.000337	CcSEcCtD
Memantine—Haemorrhage—Epirubicin—uterine cancer	0.000142	0.000336	CcSEcCtD
Memantine—Hepatitis—Epirubicin—uterine cancer	0.000142	0.000336	CcSEcCtD
Memantine—Hypoaesthesia—Epirubicin—uterine cancer	0.000141	0.000334	CcSEcCtD
Memantine—Pharyngitis—Epirubicin—uterine cancer	0.000141	0.000334	CcSEcCtD
Memantine—Urinary tract disorder—Epirubicin—uterine cancer	0.00014	0.000332	CcSEcCtD
Memantine—Oedema peripheral—Epirubicin—uterine cancer	0.00014	0.000331	CcSEcCtD
Memantine—Haematuria—Doxorubicin—uterine cancer	0.000139	0.00033	CcSEcCtD
Memantine—Connective tissue disorder—Epirubicin—uterine cancer	0.000139	0.00033	CcSEcCtD
Memantine—Urethral disorder—Epirubicin—uterine cancer	0.000139	0.00033	CcSEcCtD
Memantine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000138	0.000328	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—uterine cancer	0.000138	0.000327	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—uterine cancer	0.000137	0.000325	CcSEcCtD
Memantine—Visual impairment—Epirubicin—uterine cancer	0.000137	0.000324	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—uterine cancer	0.000136	0.000323	CcSEcCtD
Memantine—Erythema multiforme—Epirubicin—uterine cancer	0.000134	0.000318	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—uterine cancer	0.000134	0.000317	CcSEcCtD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—uterine cancer	0.000133	0.00842	CbGpPWpGaD
Memantine—Eye disorder—Epirubicin—uterine cancer	0.000132	0.000314	CcSEcCtD
Memantine—Hypersensitivity—Etoposide—uterine cancer	0.000132	0.000314	CcSEcCtD
Memantine—Tinnitus—Epirubicin—uterine cancer	0.000132	0.000313	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—uterine cancer	0.000132	0.000313	CcSEcCtD
Memantine—Flushing—Epirubicin—uterine cancer	0.000132	0.000312	CcSEcCtD
Memantine—Cardiac disorder—Epirubicin—uterine cancer	0.000132	0.000312	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—uterine cancer	0.000132	0.000312	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—uterine cancer	0.000131	0.000311	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—uterine cancer	0.000131	0.000311	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000131	0.00031	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—uterine cancer	0.00013	0.000309	CcSEcCtD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00013	0.00823	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—uterine cancer	0.00013	0.00821	CbGpPWpGaD
Memantine—Urinary tract disorder—Doxorubicin—uterine cancer	0.00013	0.000307	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—uterine cancer	0.000129	0.000306	CcSEcCtD
Memantine—Asthenia—Etoposide—uterine cancer	0.000129	0.000306	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000129	0.000306	CcSEcCtD
Memantine—Angiopathy—Epirubicin—uterine cancer	0.000129	0.000305	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—uterine cancer	0.000129	0.000305	CcSEcCtD
Memantine—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000128	0.00812	CbGpPWpGaD
Memantine—Immune system disorder—Epirubicin—uterine cancer	0.000128	0.000304	CcSEcCtD
Memantine—Mediastinal disorder—Epirubicin—uterine cancer	0.000128	0.000303	CcSEcCtD
Memantine—Chills—Epirubicin—uterine cancer	0.000127	0.000302	CcSEcCtD
Memantine—Pruritus—Etoposide—uterine cancer	0.000127	0.000301	CcSEcCtD
Memantine—Arrhythmia—Epirubicin—uterine cancer	0.000127	0.0003	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—uterine cancer	0.000126	0.0003	CcSEcCtD
Memantine—GRIN2A—Post NMDA receptor activation events—HRAS—uterine cancer	0.000126	0.00794	CbGpPWpGaD
Memantine—Alopecia—Epirubicin—uterine cancer	0.000125	0.000297	CcSEcCtD
Memantine—Mental disorder—Epirubicin—uterine cancer	0.000124	0.000295	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—uterine cancer	0.000124	0.000294	CcSEcCtD
Memantine—Malnutrition—Epirubicin—uterine cancer	0.000123	0.000293	CcSEcCtD
Memantine—Diarrhoea—Etoposide—uterine cancer	0.000123	0.000292	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—uterine cancer	0.000123	0.000291	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—uterine cancer	0.000122	0.00029	CcSEcCtD
Memantine—Flushing—Doxorubicin—uterine cancer	0.000122	0.000289	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—uterine cancer	0.000122	0.000289	CcSEcCtD
Memantine—Flatulence—Epirubicin—uterine cancer	0.000122	0.000288	CcSEcCtD
Memantine—Tension—Epirubicin—uterine cancer	0.000121	0.000287	CcSEcCtD
Memantine—Dysgeusia—Epirubicin—uterine cancer	0.000121	0.000287	CcSEcCtD
Memantine—GRIN2B—ErbB4 signaling events—PIK3CA—uterine cancer	0.000121	0.00763	CbGpPWpGaD
Memantine—Nervousness—Epirubicin—uterine cancer	0.00012	0.000284	CcSEcCtD
Memantine—Back pain—Epirubicin—uterine cancer	0.000119	0.000283	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—uterine cancer	0.000119	0.000282	CcSEcCtD
Memantine—Dizziness—Etoposide—uterine cancer	0.000119	0.000282	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—uterine cancer	0.000118	0.000281	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000118	0.00028	CcSEcCtD
Memantine—CYP2C19—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000118	0.00745	CbGpPWpGaD
Memantine—GRIN2B—Reelin signaling pathway—AKT1—uterine cancer	0.000118	0.00745	CbGpPWpGaD
Memantine—Chills—Doxorubicin—uterine cancer	0.000118	0.000279	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—uterine cancer	0.000117	0.000278	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000117	0.0074	CbGpPWpGaD
Memantine—Vision blurred—Epirubicin—uterine cancer	0.000116	0.000276	CcSEcCtD
Memantine—Alopecia—Doxorubicin—uterine cancer	0.000116	0.000275	CcSEcCtD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000116	0.00732	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—uterine cancer	0.000116	0.00731	CbGpPWpGaD
Memantine—Mental disorder—Doxorubicin—uterine cancer	0.000115	0.000273	CcSEcCtD
Memantine—Ill-defined disorder—Epirubicin—uterine cancer	0.000115	0.000272	CcSEcCtD
Memantine—Vomiting—Etoposide—uterine cancer	0.000114	0.000271	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—uterine cancer	0.000114	0.000271	CcSEcCtD
Memantine—Anaemia—Epirubicin—uterine cancer	0.000114	0.00027	CcSEcCtD
Memantine—Agitation—Epirubicin—uterine cancer	0.000113	0.000269	CcSEcCtD
Memantine—Rash—Etoposide—uterine cancer	0.000113	0.000269	CcSEcCtD
Memantine—Dermatitis—Etoposide—uterine cancer	0.000113	0.000268	CcSEcCtD
Memantine—Headache—Etoposide—uterine cancer	0.000113	0.000267	CcSEcCtD
Memantine—Flatulence—Doxorubicin—uterine cancer	0.000113	0.000267	CcSEcCtD
Memantine—Tension—Doxorubicin—uterine cancer	0.000112	0.000266	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—uterine cancer	0.000112	0.000265	CcSEcCtD
Memantine—Malaise—Epirubicin—uterine cancer	0.000111	0.000264	CcSEcCtD
Memantine—Nervousness—Doxorubicin—uterine cancer	0.000111	0.000263	CcSEcCtD
Memantine—Vertigo—Epirubicin—uterine cancer	0.000111	0.000263	CcSEcCtD
Memantine—Syncope—Epirubicin—uterine cancer	0.000111	0.000262	CcSEcCtD
Memantine—Leukopenia—Epirubicin—uterine cancer	0.00011	0.000262	CcSEcCtD
Memantine—Back pain—Doxorubicin—uterine cancer	0.00011	0.000262	CcSEcCtD
Memantine—GRIN1—Post NMDA receptor activation events—HRAS—uterine cancer	0.00011	0.00693	CbGpPWpGaD
Memantine—Palpitations—Epirubicin—uterine cancer	0.000109	0.000259	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—AKR1B10—uterine cancer	0.000109	0.00689	CbGpPWpGaD
Memantine—Loss of consciousness—Epirubicin—uterine cancer	0.000108	0.000257	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—STAR—uterine cancer	0.000108	0.00683	CbGpPWpGaD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000108	0.00682	CbGpPWpGaD
Memantine—Cough—Epirubicin—uterine cancer	0.000108	0.000255	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—uterine cancer	0.000108	0.000255	CcSEcCtD
Memantine—Convulsion—Epirubicin—uterine cancer	0.000107	0.000254	CcSEcCtD
Memantine—GRIN2B—Post NMDA receptor activation events—HRAS—uterine cancer	0.000107	0.00675	CbGpPWpGaD
Memantine—Nausea—Etoposide—uterine cancer	0.000107	0.000253	CcSEcCtD
Memantine—Hypertension—Epirubicin—uterine cancer	0.000107	0.000253	CcSEcCtD
Memantine—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000106	0.00673	CbGpPWpGaD
Memantine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000106	0.000251	CcSEcCtD
Memantine—Anaemia—Doxorubicin—uterine cancer	0.000106	0.00025	CcSEcCtD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000105	0.00667	CbGpPWpGaD
Memantine—Myalgia—Epirubicin—uterine cancer	0.000105	0.000249	CcSEcCtD
Memantine—Chest pain—Epirubicin—uterine cancer	0.000105	0.000249	CcSEcCtD
Memantine—Arthralgia—Epirubicin—uterine cancer	0.000105	0.000249	CcSEcCtD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000105	0.00664	CbGpPWpGaD
Memantine—Agitation—Doxorubicin—uterine cancer	0.000105	0.000249	CcSEcCtD
Memantine—Anxiety—Epirubicin—uterine cancer	0.000105	0.000248	CcSEcCtD
Memantine—Discomfort—Epirubicin—uterine cancer	0.000104	0.000246	CcSEcCtD
Memantine—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000104	0.00655	CbGpPWpGaD
Memantine—Malaise—Doxorubicin—uterine cancer	0.000103	0.000244	CcSEcCtD
Memantine—Dry mouth—Epirubicin—uterine cancer	0.000103	0.000244	CcSEcCtD
Memantine—Vertigo—Doxorubicin—uterine cancer	0.000103	0.000243	CcSEcCtD
Memantine—Syncope—Doxorubicin—uterine cancer	0.000102	0.000243	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—uterine cancer	0.000102	0.000242	CcSEcCtD
Memantine—Confusional state—Epirubicin—uterine cancer	0.000102	0.000241	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—AKR1B1—uterine cancer	0.000101	0.00641	CbGpPWpGaD
Memantine—Palpitations—Doxorubicin—uterine cancer	0.000101	0.000239	CcSEcCtD
Memantine—GRIN1—EPHB-mediated forward signaling—HRAS—uterine cancer	0.000101	0.00638	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—uterine cancer	0.000101	0.00638	CbGpPWpGaD
Memantine—Oedema—Epirubicin—uterine cancer	0.000101	0.000239	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—uterine cancer	0.0001	0.000238	CcSEcCtD
Memantine—Infection—Epirubicin—uterine cancer	0.0001	0.000237	CcSEcCtD
Memantine—Cough—Doxorubicin—uterine cancer	9.96e-05	0.000236	CcSEcCtD
Memantine—Shock—Epirubicin—uterine cancer	9.91e-05	0.000235	CcSEcCtD
Memantine—Convulsion—Doxorubicin—uterine cancer	9.89e-05	0.000235	CcSEcCtD
Memantine—Nervous system disorder—Epirubicin—uterine cancer	9.88e-05	0.000234	CcSEcCtD
Memantine—Thrombocytopenia—Epirubicin—uterine cancer	9.86e-05	0.000234	CcSEcCtD
Memantine—Hypertension—Doxorubicin—uterine cancer	9.86e-05	0.000234	CcSEcCtD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—uterine cancer	9.84e-05	0.00622	CbGpPWpGaD
Memantine—GRIN2B—EPHB-mediated forward signaling—HRAS—uterine cancer	9.84e-05	0.00622	CbGpPWpGaD
Memantine—Tachycardia—Epirubicin—uterine cancer	9.83e-05	0.000233	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—NFE2L2—uterine cancer	9.8e-05	0.0062	CbGpPWpGaD
Memantine—Skin disorder—Epirubicin—uterine cancer	9.78e-05	0.000232	CcSEcCtD
Memantine—Hyperhidrosis—Epirubicin—uterine cancer	9.74e-05	0.000231	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—uterine cancer	9.72e-05	0.000231	CcSEcCtD
Memantine—Myalgia—Doxorubicin—uterine cancer	9.72e-05	0.000231	CcSEcCtD
Memantine—Chest pain—Doxorubicin—uterine cancer	9.72e-05	0.000231	CcSEcCtD
Memantine—Anxiety—Doxorubicin—uterine cancer	9.69e-05	0.00023	CcSEcCtD
Memantine—Discomfort—Doxorubicin—uterine cancer	9.6e-05	0.000228	CcSEcCtD
Memantine—Anorexia—Epirubicin—uterine cancer	9.6e-05	0.000228	CcSEcCtD
Memantine—Dry mouth—Doxorubicin—uterine cancer	9.51e-05	0.000225	CcSEcCtD
Memantine—SLC22A2—Neuronal System—ABCC9—uterine cancer	9.42e-05	0.00596	CbGpPWpGaD
Memantine—Hypotension—Epirubicin—uterine cancer	9.41e-05	0.000223	CcSEcCtD
Memantine—Confusional state—Doxorubicin—uterine cancer	9.4e-05	0.000223	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—GPX3—uterine cancer	9.35e-05	0.00591	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HNF1B—uterine cancer	9.35e-05	0.00591	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CCL2—uterine cancer	9.33e-05	0.0059	CbGpPWpGaD
Memantine—Oedema—Doxorubicin—uterine cancer	9.32e-05	0.000221	CcSEcCtD
Memantine—Infection—Doxorubicin—uterine cancer	9.26e-05	0.00022	CcSEcCtD
Memantine—Musculoskeletal discomfort—Epirubicin—uterine cancer	9.18e-05	0.000218	CcSEcCtD
Memantine—Shock—Doxorubicin—uterine cancer	9.17e-05	0.000217	CcSEcCtD
Memantine—Nervous system disorder—Doxorubicin—uterine cancer	9.14e-05	0.000217	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—uterine cancer	9.12e-05	0.000216	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—HNF1B—uterine cancer	9.11e-05	0.00576	CbGpPWpGaD
Memantine—Insomnia—Epirubicin—uterine cancer	9.11e-05	0.000216	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—uterine cancer	9.1e-05	0.000216	CcSEcCtD
Memantine—Skin disorder—Doxorubicin—uterine cancer	9.05e-05	0.000215	CcSEcCtD
Memantine—Paraesthesia—Epirubicin—uterine cancer	9.04e-05	0.000214	CcSEcCtD
Memantine—Hyperhidrosis—Doxorubicin—uterine cancer	9.01e-05	0.000214	CcSEcCtD
Memantine—Dyspnoea—Epirubicin—uterine cancer	8.98e-05	0.000213	CcSEcCtD
Memantine—Somnolence—Epirubicin—uterine cancer	8.95e-05	0.000212	CcSEcCtD
Memantine—Anorexia—Doxorubicin—uterine cancer	8.88e-05	0.000211	CcSEcCtD
Memantine—Dyspepsia—Epirubicin—uterine cancer	8.87e-05	0.00021	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—HNF1B—uterine cancer	8.81e-05	0.00557	CbGpPWpGaD
Memantine—Decreased appetite—Epirubicin—uterine cancer	8.76e-05	0.000208	CcSEcCtD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.74e-05	0.00553	CbGpPWpGaD
Memantine—Hypotension—Doxorubicin—uterine cancer	8.71e-05	0.000207	CcSEcCtD
Memantine—Gastrointestinal disorder—Epirubicin—uterine cancer	8.7e-05	0.000206	CcSEcCtD
Memantine—Fatigue—Epirubicin—uterine cancer	8.68e-05	0.000206	CcSEcCtD
Memantine—Pain—Epirubicin—uterine cancer	8.61e-05	0.000204	CcSEcCtD
Memantine—Constipation—Epirubicin—uterine cancer	8.61e-05	0.000204	CcSEcCtD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.51e-05	0.00538	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.49e-05	0.000201	CcSEcCtD
Memantine—Insomnia—Doxorubicin—uterine cancer	8.43e-05	0.0002	CcSEcCtD
Memantine—Paraesthesia—Doxorubicin—uterine cancer	8.37e-05	0.000198	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—uterine cancer	8.31e-05	0.000197	CcSEcCtD
Memantine—Feeling abnormal—Epirubicin—uterine cancer	8.3e-05	0.000197	CcSEcCtD
Memantine—Somnolence—Doxorubicin—uterine cancer	8.28e-05	0.000196	CcSEcCtD
Memantine—Gastrointestinal pain—Epirubicin—uterine cancer	8.24e-05	0.000195	CcSEcCtD
Memantine—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	8.23e-05	0.00521	CbGpPWpGaD
Memantine—Dyspepsia—Doxorubicin—uterine cancer	8.2e-05	0.000195	CcSEcCtD
Memantine—Decreased appetite—Doxorubicin—uterine cancer	8.1e-05	0.000192	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—uterine cancer	8.05e-05	0.000191	CcSEcCtD
Memantine—Fatigue—Doxorubicin—uterine cancer	8.03e-05	0.000191	CcSEcCtD
Memantine—Urticaria—Epirubicin—uterine cancer	8e-05	0.00019	CcSEcCtD
Memantine—Pain—Doxorubicin—uterine cancer	7.97e-05	0.000189	CcSEcCtD
Memantine—Constipation—Doxorubicin—uterine cancer	7.97e-05	0.000189	CcSEcCtD
Memantine—Body temperature increased—Epirubicin—uterine cancer	7.96e-05	0.000189	CcSEcCtD
Memantine—Abdominal pain—Epirubicin—uterine cancer	7.96e-05	0.000189	CcSEcCtD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	7.93e-05	0.00502	CbGpPWpGaD
Memantine—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.83e-05	0.00495	CbGpPWpGaD
Memantine—Feeling abnormal—Doxorubicin—uterine cancer	7.68e-05	0.000182	CcSEcCtD
Memantine—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	7.66e-05	0.00484	CbGpPWpGaD
Memantine—Gastrointestinal pain—Doxorubicin—uterine cancer	7.62e-05	0.000181	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—CYP11A1—uterine cancer	7.62e-05	0.00482	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—AKR1C1—uterine cancer	7.44e-05	0.0047	CbGpPWpGaD
Memantine—Hypersensitivity—Epirubicin—uterine cancer	7.42e-05	0.000176	CcSEcCtD
Memantine—Urticaria—Doxorubicin—uterine cancer	7.4e-05	0.000176	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—CXCL8—uterine cancer	7.38e-05	0.00467	CbGpPWpGaD
Memantine—Abdominal pain—Doxorubicin—uterine cancer	7.37e-05	0.000175	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—uterine cancer	7.37e-05	0.000175	CcSEcCtD
Memantine—Asthenia—Epirubicin—uterine cancer	7.23e-05	0.000171	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—CDKN1B—uterine cancer	7.21e-05	0.00456	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—VEGFA—uterine cancer	7.19e-05	0.00455	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—uterine cancer	7.16e-05	0.00453	CbGpPWpGaD
Memantine—Pruritus—Epirubicin—uterine cancer	7.13e-05	0.000169	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—CXCL8—uterine cancer	7.09e-05	0.00449	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—VEGFA—uterine cancer	7.01e-05	0.00443	CbGpPWpGaD
Memantine—Diarrhoea—Epirubicin—uterine cancer	6.89e-05	0.000163	CcSEcCtD
Memantine—Hypersensitivity—Doxorubicin—uterine cancer	6.87e-05	0.000163	CcSEcCtD
Memantine—Asthenia—Doxorubicin—uterine cancer	6.69e-05	0.000159	CcSEcCtD
Memantine—Dizziness—Epirubicin—uterine cancer	6.66e-05	0.000158	CcSEcCtD
Memantine—Pruritus—Doxorubicin—uterine cancer	6.59e-05	0.000156	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	6.54e-05	0.00414	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—GPX3—uterine cancer	6.53e-05	0.00413	CbGpPWpGaD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.43e-05	0.00407	CbGpPWpGaD
Memantine—Vomiting—Epirubicin—uterine cancer	6.4e-05	0.000152	CcSEcCtD
Memantine—Diarrhoea—Doxorubicin—uterine cancer	6.38e-05	0.000151	CcSEcCtD
Memantine—Rash—Epirubicin—uterine cancer	6.35e-05	0.000151	CcSEcCtD
Memantine—Dermatitis—Epirubicin—uterine cancer	6.34e-05	0.00015	CcSEcCtD
Memantine—Headache—Epirubicin—uterine cancer	6.31e-05	0.00015	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—TP53—uterine cancer	6.24e-05	0.00395	CbGpPWpGaD
Memantine—Dizziness—Doxorubicin—uterine cancer	6.16e-05	0.000146	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—CYP11A1—uterine cancer	6.15e-05	0.00389	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TP53—uterine cancer	6.09e-05	0.00385	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—EP300—uterine cancer	6.08e-05	0.00385	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	6.06e-05	0.00383	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—uterine cancer	5.99e-05	0.00379	CbGpPWpGaD
Memantine—Nausea—Epirubicin—uterine cancer	5.98e-05	0.000142	CcSEcCtD
Memantine—Vomiting—Doxorubicin—uterine cancer	5.93e-05	0.000141	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	5.9e-05	0.00373	CbGpPWpGaD
Memantine—Rash—Doxorubicin—uterine cancer	5.88e-05	0.000139	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—uterine cancer	5.87e-05	0.000139	CcSEcCtD
Memantine—Headache—Doxorubicin—uterine cancer	5.84e-05	0.000138	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—CTNNB1—uterine cancer	5.81e-05	0.00367	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—VEGFA—uterine cancer	5.76e-05	0.00364	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	5.72e-05	0.00362	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—CTNNB1—uterine cancer	5.66e-05	0.00358	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—EZH2—uterine cancer	5.65e-05	0.00357	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	5.62e-05	0.00355	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	5.6e-05	0.00354	CbGpPWpGaD
Memantine—Nausea—Doxorubicin—uterine cancer	5.54e-05	0.000131	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	5.45e-05	0.00344	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—HRAS—uterine cancer	5.2e-05	0.00329	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—HRAS—uterine cancer	5.06e-05	0.0032	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.06e-05	0.0032	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—EP300—uterine cancer	5.06e-05	0.0032	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	4.93e-05	0.00312	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	4.79e-05	0.00303	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MET—uterine cancer	4.75e-05	0.003	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	4.64e-05	0.00294	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MET—uterine cancer	4.63e-05	0.00293	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	4.58e-05	0.0029	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—uterine cancer	4.53e-05	0.00286	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	4.52e-05	0.00286	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	4.46e-05	0.00282	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.33e-05	0.00274	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	4.33e-05	0.00274	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—SMAD3—uterine cancer	4.13e-05	0.00261	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.12e-05	0.00261	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—SMAD3—uterine cancer	4.03e-05	0.00255	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	3.78e-05	0.00239	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—HRAS—uterine cancer	3.69e-05	0.00234	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	3.68e-05	0.00233	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—HRAS—uterine cancer	3.6e-05	0.00228	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—ERBB2—uterine cancer	3.47e-05	0.00219	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	3.42e-05	0.00216	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MET—uterine cancer	3.39e-05	0.00214	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—ERBB2—uterine cancer	3.38e-05	0.00214	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	3.37e-05	0.00213	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MET—uterine cancer	3.3e-05	0.00209	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NDUFB11—uterine cancer	3.28e-05	0.00207	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SRD5A2—uterine cancer	3.28e-05	0.00207	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—AKT1—uterine cancer	3.26e-05	0.00206	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—HRAS—uterine cancer	3.26e-05	0.00206	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—AKT1—uterine cancer	3.18e-05	0.00201	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SRD5A2—uterine cancer	3.01e-05	0.0019	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NDUFB11—uterine cancer	3.01e-05	0.0019	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.98e-05	0.00188	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.98e-05	0.00188	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—HRAS—uterine cancer	2.84e-05	0.0018	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—HRAS—uterine cancer	2.77e-05	0.00175	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—uterine cancer	2.67e-05	0.00169	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—NRAS—uterine cancer	2.64e-05	0.00167	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—uterine cancer	2.6e-05	0.00165	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—NRAS—uterine cancer	2.57e-05	0.00163	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—HRAS—uterine cancer	2.49e-05	0.00158	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—ERBB2—uterine cancer	2.48e-05	0.00157	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SRD5A2—uterine cancer	2.43e-05	0.00154	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NDUFB11—uterine cancer	2.43e-05	0.00154	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—ERBB2—uterine cancer	2.41e-05	0.00153	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKR1B1—uterine cancer	2.37e-05	0.0015	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—STAR—uterine cancer	2.37e-05	0.0015	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—uterine cancer	2.27e-05	0.00144	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—KRAS—uterine cancer	2.21e-05	0.0014	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.19e-05	0.00138	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKR1B1—uterine cancer	2.18e-05	0.00138	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—STAR—uterine cancer	2.18e-05	0.00138	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—HRAS—uterine cancer	2.18e-05	0.00138	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CTNNB1—uterine cancer	2.17e-05	0.00137	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—HRAS—uterine cancer	2.12e-05	0.00134	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CTNNB1—uterine cancer	2.11e-05	0.00133	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EP300—uterine cancer	2.01e-05	0.00127	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PTEN—uterine cancer	1.99e-05	0.00126	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	1.96e-05	0.00124	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EP300—uterine cancer	1.96e-05	0.00124	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCL8—uterine cancer	1.95e-05	0.00123	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—HRAS—uterine cancer	1.93e-05	0.00122	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—uterine cancer	1.91e-05	0.00121	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—EP300—uterine cancer	1.9e-05	0.0012	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NRAS—uterine cancer	1.88e-05	0.00119	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKR1B10—uterine cancer	1.88e-05	0.00119	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—uterine cancer	1.88e-05	0.00119	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—POLD1—uterine cancer	1.86e-05	0.00118	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—uterine cancer	1.86e-05	0.00118	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.84e-05	0.00116	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.84e-05	0.00116	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NRAS—uterine cancer	1.84e-05	0.00116	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.78e-05	0.00113	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.76e-05	0.00111	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—STAR—uterine cancer	1.76e-05	0.00111	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKR1C1—uterine cancer	1.74e-05	0.0011	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—POLD1—uterine cancer	1.71e-05	0.00108	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.68e-05	0.00106	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—uterine cancer	1.62e-05	0.00102	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKR1C1—uterine cancer	1.6e-05	0.00101	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—uterine cancer	1.58e-05	0.000999	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RNF43—uterine cancer	1.56e-05	0.000986	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	1.55e-05	0.000981	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—RRM2—uterine cancer	1.55e-05	0.000981	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—DCN—uterine cancer	1.51e-05	0.000952	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCL2—uterine cancer	1.49e-05	0.000945	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	1.48e-05	0.000934	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—INHBA—uterine cancer	1.43e-05	0.000902	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—RRM2—uterine cancer	1.42e-05	0.000901	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP11A1—uterine cancer	1.42e-05	0.000897	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—DCN—uterine cancer	1.38e-05	0.000874	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—POLD1—uterine cancer	1.38e-05	0.000872	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—uterine cancer	1.38e-05	0.000871	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—uterine cancer	1.36e-05	0.000858	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—uterine cancer	1.34e-05	0.000849	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKR1C3—uterine cancer	1.34e-05	0.000847	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—STAR—uterine cancer	1.33e-05	0.000839	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.33e-05	0.000839	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.31e-05	0.00083	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.3e-05	0.000824	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.29e-05	0.000815	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKR1C1—uterine cancer	1.28e-05	0.000812	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.23e-05	0.000778	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—uterine cancer	1.22e-05	0.000769	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—uterine cancer	1.19e-05	0.00075	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—uterine cancer	1.18e-05	0.000747	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—RRM2—uterine cancer	1.15e-05	0.000727	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—uterine cancer	1.13e-05	0.000715	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—DCN—uterine cancer	1.12e-05	0.000705	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.05e-05	0.000665	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—STK11—uterine cancer	1.04e-05	0.00066	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP19A1—uterine cancer	1.04e-05	0.00066	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—POLD1—uterine cancer	1.04e-05	0.000659	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKR1C3—uterine cancer	9.93e-06	0.000628	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKR1C3—uterine cancer	9.89e-06	0.000625	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKR1C1—uterine cancer	9.74e-06	0.000616	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PGR—uterine cancer	9.64e-06	0.000609	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—STK11—uterine cancer	9.58e-06	0.000606	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP19A1—uterine cancer	9.58e-06	0.000606	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—YWHAE—uterine cancer	9.19e-06	0.000581	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FBXW7—uterine cancer	8.81e-06	0.000557	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—RRM2—uterine cancer	8.68e-06	0.000549	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—DCN—uterine cancer	8.43e-06	0.000533	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP11A1—uterine cancer	7.94e-06	0.000502	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MTHFR—uterine cancer	7.84e-06	0.000496	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—STK11—uterine cancer	7.73e-06	0.000489	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP19A1—uterine cancer	7.73e-06	0.000489	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STK11—uterine cancer	7.7e-06	0.000487	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL2—uterine cancer	7.67e-06	0.000485	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.5e-06	0.000474	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SOCS3—uterine cancer	7.21e-06	0.000456	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MTHFR—uterine cancer	7.2e-06	0.000455	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN2B—uterine cancer	6.91e-06	0.000437	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1R—uterine cancer	6.71e-06	0.000424	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—uterine cancer	6.68e-06	0.000422	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SMAD3—uterine cancer	6.31e-06	0.000399	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—uterine cancer	6.06e-06	0.000383	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGFR2—uterine cancer	6.01e-06	0.00038	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—STK11—uterine cancer	5.84e-06	0.00037	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP19A1—uterine cancer	5.84e-06	0.00037	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTHFR—uterine cancer	5.81e-06	0.000367	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.48e-06	0.000347	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.23e-06	0.000331	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ESR1—uterine cancer	5.15e-06	0.000325	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NRAS—uterine cancer	4.86e-06	0.000308	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL2—uterine cancer	4.53e-06	0.000286	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTHFR—uterine cancer	4.39e-06	0.000278	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—uterine cancer	4.36e-06	0.000276	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—uterine cancer	4.24e-06	0.000268	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—uterine cancer	4.19e-06	0.000265	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—EP300—uterine cancer	4.16e-06	0.000263	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—uterine cancer	4.01e-06	0.000253	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.87e-06	0.000245	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	3.85e-06	0.000243	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—EP300—uterine cancer	3.82e-06	0.000242	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—uterine cancer	3.78e-06	0.000239	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—uterine cancer	3.58e-06	0.000226	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—uterine cancer	3.56e-06	0.000225	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	3.5e-06	0.000221	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	3.46e-06	0.000219	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	3.3e-06	0.000209	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—uterine cancer	3.23e-06	0.000204	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—uterine cancer	3.22e-06	0.000204	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—uterine cancer	3.14e-06	0.000199	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—EP300—uterine cancer	3.08e-06	0.000195	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—uterine cancer	3.08e-06	0.000195	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EP300—uterine cancer	3.07e-06	0.000194	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—uterine cancer	2.91e-06	0.000184	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRAS—uterine cancer	2.87e-06	0.000182	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—uterine cancer	2.83e-06	0.000179	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—uterine cancer	2.52e-06	0.000159	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—uterine cancer	2.47e-06	0.000156	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—uterine cancer	2.44e-06	0.000154	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—EP300—uterine cancer	2.33e-06	0.000147	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—uterine cancer	2.31e-06	0.000146	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.28e-06	0.000144	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	2.27e-06	0.000144	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—uterine cancer	2.2e-06	0.000139	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—uterine cancer	2.1e-06	0.000133	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—uterine cancer	1.86e-06	0.000118	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—uterine cancer	1.86e-06	0.000117	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.72e-06	0.000109	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—uterine cancer	1.41e-06	8.9e-05	CbGpPWpGaD
